Furthermore, Esc triggered cell death, arrested the HCT116 cell cycle at the S phase and the HT-29 cell cycle at the G0/G1 phase, inhibited the PI3K/Akt/mTOR signaling pathway, and promoted anti-CRC effects both in vitro and in vivo. The gene discussed is AKT1; the disease is colorectal carcinoma.